<unk> , sold under the brand name Verquvo, is a medication used to reduce the risk of cardiovascular death and heart failure, who have had a recent hospitalization or the need to receive IV medications, and have an ejection fraction of less than 45 percent to reduce the risk of dying and the need to be hospitalized. It is taken by mouth. The common dosing regimen for patients is once each day with food. If a patient forgets to take the medication, they are advised to take the medication when they remember. Patients are advised not to take two pills on the same way. Common side effects include low blood pressure and low red cell count (anemia).<unk>  is a soluble guanylate cyclase (sGC) stimulator. It was approved for medical use in the United States in January 2021, and for use in the European Union in July 2021.
Vericiguat
Riociguat
Bosentan
Ambrisentan
Sitaxentan
Colestilan
Darusentan
Macitentan